Precipio Second-Generation HemeScreen Assays
Aug 16, 2022
Precipio has launched the second generation of its HemeScreen panels. The new assays reduce time and labor by eliminating confirmation step, reducing the process to a single step, the company said.
The New Haven, Connecticut-based cancer diagnostics company said the second-generation panels reduces the bench work needed to complete an assay by about 25 percent and shortens the turn-around time by eliminating that positive confirmation step required in first-generation panels. The new version of the assays delivers positive and negative results within about three hours.